Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CREDIT-1: IBI306 in non-familial hypercholesterolemia (China)
CTR20200108Phase 3Completed
- Sponsor
- InnoCare Pharma
- Start
- Mar 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of tafolecimab in hypercholesterolemia, sponsored by InnoCare Pharma. Started Mar 2020; status: completed.
02
Drugs
tafolecimab
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on CTR20200108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200108.